Nova Eye USA Sales Growth Opportunity

Clinically Significant Features iTrack TM Advance vs Other MIGS Designed to reduce the elevated IOP associated with glaucoma by improving trabecular flow through the natural outflow pathway. Device Company Procedure iTrack T Advance Nova Eye Medical Canaloplasty KDB(1) New World Medical Goniotomy OMNI(1) Sight Sciences Patient Population Natural Outflow Pathway Implant- Preserves free Tissue Trabecular Meshwork Schlemm's canal Collector Channels Mild-moderate glaucoma Mild-moderate i.e. cutting of tissue Canaloplasty followed by goniotomy i.e. cutting of tissue glaucoma Mild-moderate glaucoma Mild-moderate iStent(1) Micro-trabecular Glaukos bypass stent Hydrus(1) Micro-trabecular glaucoma Mild-moderate Alcon bypass stent glaucoma (1) Based on collation of information in Marketscope 2023 Glaucoma Surgical Device Market Report and company information on websites X × × X Х х × nova-eye.com | 11

View entire presentation